Logo image of BLCO.CA

BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis

TSX:BLCO - Toronto Stock Exchange - CA0717051076 - Common Stock - Currency: CAD

15.67  -0.51 (-3.15%)

Fundamental Rating

4

BLCO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Equipment & Supplies industry. While BLCO is still in line with the averages on profitability rating, there are concerns on its financial health. BLCO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLCO had positive earnings in the past year.
In the past year BLCO had a positive cash flow from operations.
In multiple years BLCO reported negative net income over the last 5 years.
Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of -2.70%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of BLCO (-5.69%) is better than 100.00% of its industry peers.
BLCO has a Return On Invested Capital of 0.78%. This is amongst the best in the industry. BLCO outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLCO is in line with the industry average of 0.78%.
Industry RankSector Rank
ROA -2.7%
ROE -5.69%
ROIC 0.78%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

The Operating Margin of BLCO (2.63%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
BLCO has a better Gross Margin (60.03%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 2.63%
PM (TTM) N/A
GM 60.03%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
Compared to 1 year ago, BLCO has more shares outstanding
Compared to 5 years ago, BLCO has more shares outstanding
The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BLCO has an Altman-Z score of 0.74. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
BLCO has a Altman-Z score of 0.74. This is amongst the best in the industry. BLCO outperforms 86.67% of its industry peers.
BLCO has a Debt/Equity ratio of 0.75. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
BLCO has a Debt to Equity ratio of 0.75. This is comparable to the rest of the industry: BLCO outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Altman-Z 0.74
ROIC/WACC0.11
WACC7.02%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

BLCO has a Current Ratio of 1.56. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
BLCO's Current ratio of 1.56 is in line compared to the rest of the industry. BLCO outperforms 53.33% of its industry peers.
A Quick Ratio of 0.96 indicates that BLCO may have some problems paying its short term obligations.
With a Quick ratio value of 0.96, BLCO perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.96
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

4

3. Growth

3.1 Past

BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.39%.
Looking at the last year, BLCO shows a quite strong growth in Revenue. The Revenue has grown by 11.94% in the last year.
The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-32.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)11.94%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%3.46%

3.2 Future

BLCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.11% yearly.
The Revenue is expected to grow by 4.77% on average over the next years.
EPS Next Y-19.13%
EPS Next 2Y13.23%
EPS Next 3Y19.77%
EPS Next 5Y24.11%
Revenue Next Year5.39%
Revenue Next 2Y5.42%
Revenue Next 3Y5.22%
Revenue Next 5Y4.77%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.74, the valuation of BLCO can be described as rather expensive.
Based on the Price/Earnings ratio, BLCO is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.25, BLCO is valued at the same level.
With a Price/Forward Earnings ratio of 14.28, BLCO is valued correctly.
Based on the Price/Forward Earnings ratio, BLCO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, BLCO is valued a bit cheaper.
Industry RankSector Rank
PE 23.74
Fwd PE 14.28
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BLCO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLCO is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.45
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

BLCO has a very decent profitability rating, which may justify a higher PE ratio.
BLCO's earnings are expected to grow with 19.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.23%
EPS Next 3Y19.77%

More info and screens

0

5. Dividend

5.1 Amount

BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAUSCH + LOMB CORP

TSX:BLCO (5/30/2025, 7:00:00 PM)

15.67

-0.51 (-3.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)N/A N/A
Inst Owners10.12%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap5.54B
Analysts72.63
Price Target21.89 (39.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-178.13%
Min EPS beat(2)-360.35%
Max EPS beat(2)4.09%
EPS beat(4)3
Avg EPS beat(4)-86.35%
Min EPS beat(4)-360.35%
Max EPS beat(4)6.68%
EPS beat(8)6
Avg EPS beat(8)-34.35%
EPS beat(12)9
Avg EPS beat(12)-16.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.61%
Min Revenue beat(2)-3.07%
Max Revenue beat(2)-0.16%
Revenue beat(4)1
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)0.92%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.63%
PT rev (3m)-28.02%
EPS NQ rev (1m)-42.37%
EPS NQ rev (3m)-55.44%
EPS NY rev (1m)-24.76%
EPS NY rev (3m)-37.74%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-1.39%
Revenue NY rev (1m)0.63%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 23.74
Fwd PE 14.28
P/S 0.83
P/FCF N/A
P/OCF 24.16
P/B 0.63
P/tB N/A
EV/EBITDA 15.45
EPS(TTM)0.66
EY4.21%
EPS(NY)1.1
Fwd EY7%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)0.65
OCFY4.14%
SpS18.87
BVpS24.85
TBVpS-6.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE -5.69%
ROCE 1.09%
ROIC 0.78%
ROICexc 0.8%
ROICexgc 2.61%
OM 2.63%
PM (TTM) N/A
GM 60.03%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexcg growth 3Y-21.86%
ROICexcg growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Debt/EBITDA 8.57
Cap/Depr 77.31%
Cap/Sales 6.92%
Interest Coverage 250
Cash Conversion 29.7%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 0.96
Altman-Z 0.74
F-Score3
WACC7.02%
ROIC/WACC0.11
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-19.13%
EPS Next 2Y13.23%
EPS Next 3Y19.77%
EPS Next 5Y24.11%
Revenue 1Y (TTM)11.94%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%3.46%
Revenue Next Year5.39%
Revenue Next 2Y5.42%
Revenue Next 3Y5.22%
Revenue Next 5Y4.77%
EBIT growth 1Y-42.79%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year40.8%
EBIT Next 3Y21.5%
EBIT Next 5Y16.29%
FCF growth 1Y-244.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.96%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%